During the past decade, The Clinical Trial Center, LLC conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 33 clinical trials were completed, i.e. on average, 117.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 18 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Clinical Trial Center, LLC" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 5 trials sponsored, "TauRx Therapeutics Ltd" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored and "Eisai Inc." with 3 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Clinical Trial Center, LLC" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "The Clinical Trial Center, LLC" are "Alzheimer's Disease" (25 trials), "Alzheimer Disease" (12 trials), "Hot Flashes" (3 trials), "Overactive Bladder" (3 trials) and "Type 2 Diabetes" (3 trials). Many other conditions were trialed in "The Clinical Trial Center, LLC" in a lesser frequency.

Most popular intervention types in "The Clinical Trial Center, LLC" are "Drug" (72 trials), "Other" (3 trials), "Biological" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "placebo" (6 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Donanemab" (3 trials) and "Placebo Control" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Clinical Trial Center, LLC" are 62 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Clinical Trial Center, LLC". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in The Clinical Trial Center, LLC, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in The Clinical Trial Center, LLC, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".